Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Wels

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Pharmacokinetics and Biopharmaceutics|August 1, 1983
Steady-state moxalactam pharmacokinetics in patients: noncompartmental versus two-compartmental analysisD J Swanson, D P Reitberg, I L Smith, et al.
Annals of Surgery|January 1, 1985
Clinical risk factors for prolonged PT/PTT in abdominal sepsis patients treated with moxalactam or tobramycin plus clindamycinJ G Baxter, D A Marble, L R Whitfield, et al.
American Journal of Therapeutics|June 1, 1995
A Double-Blind, Randomized Comparison of Aztreonam Plus Clindamycin with Tobramycin Plus Clindamycin in Abdominal InfectionsCharles H. Ballow, Philip B. Wels, Lynda S. Welage, et al.
Toxicology|September 28, 2015
Progression of micronutrient alteration and hepatotoxicity following acute PCB126 exposureW D Klaren, G S Gadupudi, B Wels, et al.
Therapeutic Drug Monitoring|December 1, 1993
The development of a bedside algorithm capable of targeting anti-endotoxins to the responder subpopulationsM C Birmingham, D E Nix, T J Cumbo, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1990
Comparative evaluation of the pharmacokinetics of N-methylthiotetrazole following administration of cefoperazone, cefotetan, and cefmetazoleL S Welage, M T Borin, J H Wilton, et al.
Annals of Surgery|July 1, 1983
A randomized clinical trial of moxalactam alone versus tobramycin plus clindamycin in abdominal sepsisJ J Schentag, P B Wels, D P Reitberg, et al.
Reviews of Infectious Diseases|November 1, 1985
Pharmacokinetics and extravascular penetration of aztreonam in patients with abdominal sepsisN E Winslade, I L Smith, G W Simons, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Pharmacokinetics and Biopharmaceutics|August 1, 1983
Steady-state moxalactam pharmacokinetics in patients: noncompartmental versus two-compartmental analysisD J Swanson, D P Reitberg, I L Smith, et al.
Annals of Surgery|January 1, 1985
Clinical risk factors for prolonged PT/PTT in abdominal sepsis patients treated with moxalactam or tobramycin plus clindamycinJ G Baxter, D A Marble, L R Whitfield, et al.
American Journal of Therapeutics|June 1, 1995
A Double-Blind, Randomized Comparison of Aztreonam Plus Clindamycin with Tobramycin Plus Clindamycin in Abdominal InfectionsCharles H. Ballow, Philip B. Wels, Lynda S. Welage, et al.
Toxicology|September 28, 2015
Progression of micronutrient alteration and hepatotoxicity following acute PCB126 exposureW D Klaren, G S Gadupudi, B Wels, et al.
Therapeutic Drug Monitoring|December 1, 1993
The development of a bedside algorithm capable of targeting anti-endotoxins to the responder subpopulationsM C Birmingham, D E Nix, T J Cumbo, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1990
Comparative evaluation of the pharmacokinetics of N-methylthiotetrazole following administration of cefoperazone, cefotetan, and cefmetazoleL S Welage, M T Borin, J H Wilton, et al.
Annals of Surgery|July 1, 1983
A randomized clinical trial of moxalactam alone versus tobramycin plus clindamycin in abdominal sepsisJ J Schentag, P B Wels, D P Reitberg, et al.
Reviews of Infectious Diseases|November 1, 1985
Pharmacokinetics and extravascular penetration of aztreonam in patients with abdominal sepsisN E Winslade, I L Smith, G W Simons, et al.
Pageof 2